Court rules pharmacies can pursue racketeering claims against major PBMs

By Allison Bell

News January 26, 2026 at 05:09 PM

Share & Print

What You Need To Know

The new ruling is part of a big wave of insulin antitrust cases.
The court dismissed antitrust suits brought by parties that did not directly interact with the PBMs or manufacturers.
The plaintiffs with survivng cases are pharmacies.

More From HR Executive

NOT FOR REPRINT

© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.